佐力药业: 信息披露事务管理制度（2025年8月）

Core Points - The document outlines the information disclosure management system of Zhejiang Zoli Pharmaceutical Co., Ltd, emphasizing the importance of timely, accurate, and complete disclosure of information that may significantly impact the company's stock and derivatives trading prices [1][2][3]. Group 1: General Principles - The company and other information disclosure obligors must fulfill their disclosure obligations in a timely manner, ensuring that the information is true, accurate, complete, and easy to understand [3][4]. - All disclosed information must be made available to all investors simultaneously, without prior disclosure to any individual or organization [2][3]. - In the event of insider information, those privy to such information must not disclose or use it for insider trading before it is legally disclosed [3][4]. Group 2: Disclosure Procedures - The company must publish disclosed information on the stock exchange's website and in media that meet the requirements set by the China Securities Regulatory Commission [4][5]. - If there is a leak of undisclosed significant information or abnormal stock trading, the company must take immediate measures to report to the Shenzhen Stock Exchange and announce the situation [4][5]. - The company can apply for a delay in disclosure under certain conditions, such as if the information has not leaked and relevant insiders have committed to confidentiality [6][7]. Group 3: Reporting Requirements - The company is required to disclose periodic reports, including annual, semi-annual, and quarterly reports, within specified timeframes after the end of each accounting period [7][8]. - Any significant risks that may adversely affect the company's core competitiveness and future development must be disclosed [8][9]. - If there are significant changes in expected annual performance, the company must issue a profit warning within one month after the end of the accounting year [9][10]. Group 4: Management of Disclosure - The board of directors is responsible for establishing and ensuring the effective implementation of the information disclosure management system [33][34]. - The company secretary is tasked with managing information disclosure and ensuring compliance with relevant laws and regulations [34][35]. - All departments and subsidiaries must designate responsible individuals to report significant information to the company secretary [44][45]. Group 5: Confidentiality and Penalties - Information disclosure obligors and those who come into contact with undisclosed information have a confidentiality obligation and must not leak any undisclosed information [59][60]. - Violations of the disclosure management system may result in disciplinary actions, including warnings or termination, and potential legal liability for significant breaches [61][62].